Gain Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-3.2M | $-3.3M | $20.8K | $81.6K |
| FY2021 | $-12.4M | $-12.5M | $94.2K | $839.4K |
| FY2022 | $-14.7M | $-14.8M | $119.0K | $1.5M |
| FY2023 | $-18.9M | $-18.9M | $15.4K | $3.3M |
| FY2024 | $-18.9M | $-18.9M | $22.5K | $2.4M |
| FY2025 | $-18.5M | $-18.5M | — | $1.8M |